FAGAN ASSOCIATES, INC. - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
FAGAN ASSOCIATES, INC. ownership history of BAXTER INTL INC
ValueSharesWeighting
Q2 2023$215,635
-14.2%
4,733
-4.1%
0.05%
-22.4%
Q4 2022$251,435
-5.5%
4,9330.0%0.07%
-9.5%
Q3 2022$266,000
-16.1%
4,9330.0%0.07%
-12.9%
Q2 2022$317,000
-17.2%
4,9330.0%0.08%
+7.6%
Q1 2022$383,000
-9.5%
4,9330.0%0.08%
-1.2%
Q4 2021$423,000
+6.5%
4,9330.0%0.08%
-7.0%
Q3 2021$397,0000.0%4,9330.0%0.09%
+1.2%
Q2 2021$397,000
-4.6%
4,9330.0%0.08%
-12.4%
Q1 2021$416,000
+59.4%
4,933
+51.8%
0.10%
+47.0%
Q4 2020$261,0000.0%3,2500.0%0.07%
-12.0%
Q3 2020$261,000
-6.8%
3,2500.0%0.08%
-15.7%
Q2 2020$280,000
+6.1%
3,2500.0%0.09%
-15.2%
Q1 2020$264,000
-2.9%
3,2500.0%0.10%
+19.3%
Q4 2019$272,000
-4.2%
3,2500.0%0.09%
-20.0%
Q3 2019$284,000
+0.7%
3,250
-5.7%
0.11%
-4.3%
Q2 2019$282,000
+0.7%
3,4450.0%0.12%
-4.2%
Q1 2019$280,000
+23.3%
3,4450.0%0.12%
+2.6%
Q4 2018$227,000
-20.4%
3,445
-6.9%
0.12%
-0.8%
Q3 2018$285,000
+4.4%
3,7000.0%0.12%
-4.1%
Q2 2018$273,000
+9.2%
3,700
-3.9%
0.12%
+15.0%
Q1 2018$250,000
+0.4%
3,8500.0%0.11%
+5.9%
Q4 2017$249,000
+2.9%
3,8500.0%0.10%
-15.8%
Q3 2017$242,000
+3.9%
3,8500.0%0.12%
-0.8%
Q2 2017$233,000
-13.4%
3,8500.0%0.12%
-32.4%
Q2 2015$269,000
+1.9%
3,8500.0%0.18%
-8.7%
Q1 2015$264,000
-6.4%
3,8500.0%0.20%
-12.5%
Q4 2014$282,000
+2.2%
3,8500.0%0.22%
-1.3%
Q3 2014$276,000
-0.7%
3,8500.0%0.23%
-4.6%
Q2 2014$278,000
-2.1%
3,8500.0%0.24%
-3.3%
Q1 2014$284,0003,8500.25%
Other shareholders
BAXTER INTL INC shareholders Q2 2022
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders